Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world study.

Saved in:
Bibliographic Details
Title: Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world study.
Authors: Martínez-Lago N; Medical Oncology Department and Health Research Institute of Santiago de Compostela (IDIS), Santiago University Clinical Hospital (CHUS), Santiago de Compostela, Spain. Nieves.Purificacion.Martinez.Lago@sergas.es., Carnero López B; Medical Oncology Department, Lucus Augusti University Hospital, Lugo, Spain., de la Cámara Gómez JC; Medical Oncology Department, A Coruña University Hospital, A Coruña, Spain., Vázquez Rivera F; Medical Oncology Department and Health Research Institute of Santiago de Compostela (IDIS), Santiago University Clinical Hospital (CHUS), Santiago de Compostela, Spain., Fernández Montes A; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., Cousillas Castiñeiras A; Medical Oncology Department, Pontevedra University Hospital Complex, Pontevedra, Spain., De Dios Alvarez N; Medical Oncology Department, Álvaro Cunqueiro University Hospital, Vigo, Spain., Covela Rúa M; Medical Oncology Department, Lucus Augusti University Hospital, Lugo, Spain., Varela Ponte R; Radiology Department, Associate Professor of Health Sciences, Santiago de Compostela University Clinical Hospital (CHUS), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Agraso Busto S; Medical Oncology Department, Ferrol University Hospital Complex, Ferrol, Spain., Carral Maseda A; Medical Oncology Department, A Coruña University Hospital, A Coruña, Spain., Salgado Fernández M; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., Reboredo López M; Medical Oncology Department, A Coruña University Hospital, A Coruña, Spain.
Source: BMC cancer [BMC Cancer] 2026 Feb 15; Vol. 26 (1). Date of Electronic Publication: 2026 Feb 15.
Publication Type: Journal Article; Multicenter Study; Comparative Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2407
DOI:10.1186/s12885-026-15745-5